How much funding has FIRE1 raised?

FIRE1 has raised $250.5M in total funding, most recently a Series D round.

Who are FIRE1's investors?

FIRE1's investors include Polaris Partners, Novo Holdings A/S, Elevage Medical Technologies, Andera Partners, Gilde Healthcare, Medtronic.

Where is FIRE1 headquartered?

FIRE1 is headquartered in Dublin, Ireland.

FIRE1

formerly Foundry Innovation & Research 1, Limited

Helping millions with heart failure get their normal back

Dublin, Ireland · Founded 2014 · $250.5M raised

Healthcare

Headquarters: Dublin
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: fire1foundry.com
Total Funding: $250.5M
Last Round: $120.0M Series DJan 2025
Rounds: 5

About

FIRE1 (Foundry Innovation & Research 1) is a medical device company developing the NORM system, a revolutionary implantable heart failure management platform. Founded in 2014 and headquartered in Dublin, Ireland, FIRE1's NORM device enables remote daily monitoring of cardiac status via a simple implant, a wearable belt, and a smartphone app. The system alerts clinicians to problematic readings, helping heart failure patients regain independence while staying connected to their medical team. FIRE1 raised $120M to fund its pivotal clinical trial.

Summary

FIRE1 is a Healthcare company based in Dublin, Ireland, founded in 2014. It has raised $250.5M in total across 5 rounds, most recently a $120.0M Series D round in Jan 2025. Investors include Polaris Partners, Novo Holdings A/S and Elevage Medical Technologies.

LinkedIn X (Twitter)